SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-16-006161
Filing Date
2016-08-10
Accepted
2016-08-10 08:01:19
Documents
59
Period of Report
2016-08-10

Document Format Files

Seq Description Document Type Size
1 6-K zk1618823.htm 6-K 15538
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 46769
3 EXHIBIT 99.2 exhibit_99-2.htm EX-99.2 559296
10 image2.jpg GRAPHIC 2522
  Complete submission text file 0001178913-16-006161.txt   3393414

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT fomx-20160630.xml EX-101.INS 708075
5 XBRL TAXONOMY EXTENSION SCHEMA fomx-20160630.xsd EX-101.SCH 31949
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fomx-20160630_cal.xml EX-101.CAL 59025
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fomx-20160630_def.xml EX-101.DEF 131973
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE fomx-20160630_lab.xml EX-101.LAB 246034
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fomx-20160630_pre.xml EX-101.PRE 211662
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36621 | Film No.: 161820012
SIC: 2833 Medicinal Chemicals & Botanical Products